Back to Search Start Over

Genotype-phenotype correlations in RHOBTB2-associated neurodevelopmental disorders

Authors :
Franziska Langhammer
Reza Maroofian
Rueda Badar
Anne Gregor
Michelle Rochman
Jeffrey B. Ratliff
Marije Koopmans
Theresia Herget
Maja Hempel
Fanny Kortüm
Delphine Heron
Cyril Mignot
Boris Keren
Susan Brooks
Christina Botti
Bruria Ben-Zeev
Emanuela Argilli
Elliot H. Sherr
Vykuntaraju K. Gowda
Varunvenkat M. Srinivasan
Somayeh Bakhtiari
Michael C. Kruer
Mustafa A. Salih
Alma Kuechler
Eric A. Muller
Karli Blocker
Outi Kuismin
Kristen L. Park
Aaina Kochhar
Kathleen Brown
Subhadra Ramanathan
Robin Dawn Clark
Magdeldin Elgizouli
Gia Melikishvili
Nazhi Tabatadze
Zornitza Stark
Ghayda M. Mirzaa
Jinfon Ong
Ute Grasshoff
Andrea Bevot
Lydia von Wintzingerode
Rami Abou Jamra
Yvonne Hennig
Paula Goldenberg
Chadi Al Alam
Majida Charif
Redouane Boulouiz
Mohammed Bellaoui
Rim Amrani
Fuad Al Mutairi
Abdullah M. Tamim
Firdous Abdulwahab
Fowzan S. Alkuraya
Ebtissal Mohammad Khouj
Javeria Raza Alvi
Tipu Sulta
Narges Hashemi
Ehsan Ghayoor Karimiani
Farah Ashrafzadeh
Shima Imannezhad
Stephanie Efthymiou
Henry Houlden
Heinrich Sticht
Christiane Zweier
Source :
Genetics in Medicine. :100885
Publication Year :
2023
Publisher :
Elsevier BV, 2023.

Abstract

PURPOSE Missense variants clustering in the BTB domain region of RHOBTB2 cause a developmental and epileptic encephalopathy (DEE) with early-onset seizures and severe intellectual disability. METHODS By international collaboration we assembled individuals with pathogenic RHOBTB2 variants and a variable spectrum of neurodevelopmental disorders (NDDs). By western blotting we investigated the consequences of missense variants in vitro. RESULTS In accordance with previous observations, de novo heterozygous missense variants in the BTB domain region led to a severe DEE in 16 individuals. We now identified also de novo missense variants in the GTPase domain in six individuals with apparently more variable neurodevelopmental phenotypes with or without epilepsy. In contrast to variants in the BTB domain region, variants in the GTPase domain do not impair proteasomal degradation of RHOBTB2 in vitro, indicating different functional consequences.Furthermore, we observed bi-allelic splice-site and truncating variants in nine families with variable neurodevelopmental phenotypes, indicating that complete loss of RHOBTB2 is pathogenic as well. CONCLUSION By identifying phenotype-genotype correlations regarding location and consequences of de novo missense variants in RHOBTB2 and by identifying bi-allelic truncating variants, we further delineate and expand the molecular and clinical spectrum of RHOBTB2 related disorders including both autosomal dominant and recessive NDDs.

Details

ISSN :
10983600
Database :
OpenAIRE
Journal :
Genetics in Medicine
Accession number :
edsair.doi.dedup.....9259e38c2580f1a1c655eb69992c7df6
Full Text :
https://doi.org/10.1016/j.gim.2023.100885